Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macitentan in Portopulmonary Hypertension (Randomized Double-Blind Placebo-Controlled Phase 4 Study)
2014-004624-21Phase 4Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in portopulmonary hypertension (POPH) comparing Macitentan with Placebo (2 arms). Started Dec 2014; status: completed.
02
Drugs
macitentan
03
Conditions
portopulmonary hypertension (POPH)
Beyond the preview
Go deeper on 2014-004624-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004624-21.